These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2195055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW, Hunter KW, Wilson SR.
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [Abstract] [Full Text] [Related]

  • 4. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF, Concepcion NF.
    Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
    [Abstract] [Full Text] [Related]

  • 5. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.
    van Furth R, Leijh PC, Klein F.
    J Infect Dis; 1984 Apr; 149(4):511-7. PubMed ID: 6202804
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB.
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR, Augustine NH, Shigeoka AO.
    Am J Med; 1984 Mar 30; 76(3A):61-6. PubMed ID: 6424458
    [Abstract] [Full Text] [Related]

  • 14. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW.
    Pediatr Infect Dis J; 1988 May 30; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [Abstract] [Full Text] [Related]

  • 15. Enhanced killing of group B streptococci in vitro by penicillin and opsonophagocytosis with intravenous immunoglobulin.
    Miller PS, Schauf V, Salo RJ.
    J Infect Dis; 1990 Jun 30; 161(6):1225-30. PubMed ID: 2111840
    [Abstract] [Full Text] [Related]

  • 16. Opsonic activity and composition of five intramuscular gammaglobulin preparations.
    van Furth R, Braat AG, Leijh PC, Klein F.
    J Infect; 1986 Nov 30; 13(3):269-75. PubMed ID: 2432132
    [Abstract] [Full Text] [Related]

  • 17. Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.
    Hill HR, Shigeoka AO, Augustine NH, Pritchard D, Lundblad JL, Schwartz RS.
    J Exp Med; 1984 Jun 01; 159(6):1618-28. PubMed ID: 6374010
    [Abstract] [Full Text] [Related]

  • 18. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB, Edwards MS, Baker CJ.
    J Infect Dis; 1988 Oct 01; 158(4):724-30. PubMed ID: 3049837
    [Abstract] [Full Text] [Related]

  • 19. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P, Nicholson-Weller A, Wessels MR.
    J Immunol; 1999 Sep 01; 163(5):2761-8. PubMed ID: 10453019
    [Abstract] [Full Text] [Related]

  • 20. Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain.
    Kim KS, Kang JH, Concepcion NF, Anthony BF.
    Infect Immun; 1986 Jun 01; 52(3):908-10. PubMed ID: 3519467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.